Access in all areas? A round up of developments in market access and health technology assessment: part 1
Open Access
- 1 October 2023
- journal article
- editorial
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 12 (10) , e230129
Abstract
In this new series reviewing recent developments in market access, we highlight publications investigating health technology assessment (HTA) guidance, review processes and outcomes across the world and discuss how forthcoming changes in the HTA and regulatory environment in the European Union may allow for more consistency in decision making.Keywords
This publication has 5 references indexed in Scilit:
- Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional studyThe Lancet Oncology, 2023
- A review of HTA guidelines on societal and novel value elementsInternational Journal of Technology Assessment in Health Care, 2023
- Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countriesESMO Open, 2023
- What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countriesHealth Policy, 2019
- Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3]Value in Health, 2018